Time to revisit reduced-dose radiotherapy for PCNSL?

Maciej Tatarczuch · 2024

Read Time to revisit reduced-dose radiotherapy for PCNSL? by Maciej Tatarczuch (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11707613.txt.

Description

Maciej Tatarczuch wrote a 2024 commentary on the best follow-up therapy for primary central nervous system lymphoma, a brain cancer. The piece discusses a large single-center study of 559 patients treated between 1983 and 2020. The study tracked how consolidation therapy after first treatment shifted over time, away from whole-brain radiation and toward stem cell transplant or gentler chemotherapy.

Radiation controls the disease longer but can damage thinking, especially past age 60. Transplant avoids that harm but is itself hard on older, frailer patients. The commentary weighs the reduced-dose radiation option in the study's title and asks whether it deserves a fresh look. Patients who reached complete response did well long term. Tatarczuch stresses how hard it is to compare gentler regimens when their very definition is fuzzy.

Catalog record

CREATORMaciej Tatarczuch
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE7 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11707613

Browse the full library · About the Tower of Babel